SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 38.19 |
| Enterprise Value ($M) | 7.17 |
| Book Value ($M) | 5.67 |
| Book Value / Share | 1.74 |
| Price / Book | 6.74 |
| NCAV ($M) | 2.96 |
| NCAV / Share | 0.91 |
| Price / NCAV | 12.92 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -6.18 |
| Return on Assets (ROA) | -0.96 |
| Return on Equity (ROE) | -1.17 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.40 |
| Current Ratio | 7.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 45.29 |
| Assets | 48.00 |
| Liabilities | 42.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | StemPoint Capital LP | 14.30 | 13.43 | |
| 13G | Perceptive Advisors Llc | 5.10 | ||
| 13G/A | Alyeska Investment Group, L.P. | 0.80 | -85.77 | |
| 13G/A | Nantahala Capital Management, LLC | 9.99 | ||
| 13G | Regents Of The University Of California | 4.16 | -4.00 | |
| 13G | Nantahala Capital Partners Limited Partnership | 5.28 | ||
| 13G/A | Stonepine Capital Management, LLC | 7.30 | 22.85 | |
| 13G/A | Goldman Sachs Group Inc | 2.40 | -54.04 | |
| 13D/A | Column Group Iii Gp, Lp | 34.60 | -0.87 | |
| 13G | Ra Capital Management, L.p. | 9.99 | ||
| 13G/A | BML Investment Partners, L.P. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 637 | 1,963 | 32.45 | |
| 454 | 4,409 | 10.30 | |
| 3,037 | 8,789 | 34.55 | |
| 2,284 | 12,225 | 18.68 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SNYR – Synergy CHC Corp. | SONN – Sonnet BioTherapeutics Holdings, Inc. |
| SPRB – Spruce Biosciences, Inc. | SXTC – China SXT Pharmaceuticals, Inc. |
| SXTP – 60 Degrees Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io